Madrid’s 9.5M VRS Vaccine Purchase
- MADRID (AP) — The Community of Madrid's government council has approved a €9.5 million investment to purchase 44,000 doses of the respiratory syncytial virus (RSV) vaccine for infants...
- The free vaccinations will be administered starting next fall, with a single injection given in Madrid hospitals' maternity wards and children's university hospitals in the capital, according to...
- Madrid launched its infant immunization campaign two years ago.
Madrid Invests Millions in RSV Vaccine for Infants
Table of Contents
- Madrid Invests Millions in RSV Vaccine for Infants
- Madrid’s Investment in RSV Vaccines: Your Questions Answered
- What is the Respiratory Syncytial Virus (RSV)?
- Why is Madrid investing in RSV vaccines?
- How much is Madrid investing in RSV vaccines for infants?
- How many doses of the RSV vaccine will be purchased for infants?
- Who is eligible for the free RSV vaccinations in Madrid?
- When will the RSV vaccinations for infants begin?
- Where will the infant RSV vaccines be administered?
- What illnesses does the RSV vaccine protect against?
- Has Madrid launched an infant immunization campaign previously?
- What were the vaccination rates for infants in the last campaign?
- How have RSV vaccinations impacted RSV cases in Madrid?
- Have RSV vaccinations reduced hospital admissions in Madrid?
- Are RSV vaccines also available for adults in Madrid?
- What illnesses in adults are they designed to prevent?
- What are the key takeaways from Madrid’s RSV vaccination program?
MADRID (AP) — The Community of Madrid’s government council has approved a €9.5 million investment to purchase 44,000 doses of the respiratory syncytial virus (RSV) vaccine for infants up to six months old. The vaccine aims to protect against illnesses such as bronchiolitis and pneumonia.
The free vaccinations will be administered starting next fall, with a single injection given in Madrid hospitals’ maternity wards and children’s university hospitals in the capital, according to regional officials.
High Vaccination Rates Reported
Madrid launched its infant immunization campaign two years ago. During the last campaign, which ran from Oct. 1, 2024, to March 31, 82% of children up to six months old were vaccinated. This figure represents a 4% increase compared to the previous campaign. Vaccination coverage reached 96% among newborns, officials said.
Decline in RSV Cases
The General Directorate of Public health reports that this initiative has led to a 17.6% decrease in RSV cases registered in primary care compared to the 2023/24 period. The reduction is even more significant, at 51.1%, compared to 2022, before the vaccine was administered.
Officials also stated that the vaccination program has prevented 90% of hospital admissions for babies up to one year old.
Vaccines for Elderly and Vulnerable Adults
Madrid’s public health system will soon receive 100,000 doses of RSV vaccines to protect elderly and vulnerable adults from severe pneumonia and complications such as heart failure. Madrid claims to be at the forefront of Spanish regions in implementing this measure.
About RSV
The respiratory syncytial virus is a leading cause of respiratory infections in children under one year old, and also in individuals over 65 or those with underlying health conditions.
Madrid’s Investment in RSV Vaccines: Your Questions Answered
What is the Respiratory Syncytial Virus (RSV)?
RSV,or respiratory syncytial virus,is a common virus that causes respiratory infections. It is a leading cause of respiratory infections in children under one year old and also affects individuals over 65, or those with underlying health conditions.
Why is Madrid investing in RSV vaccines?
Madrid’s government is investing millions in RSV vaccines too protect infants and vulnerable adults from the virus and its complications.
How much is Madrid investing in RSV vaccines for infants?
The Community of Madrid is investing €9.5 million.
How many doses of the RSV vaccine will be purchased for infants?
The investment will purchase 44,000 doses of the RSV vaccine.
Who is eligible for the free RSV vaccinations in Madrid?
The free vaccinations are for infants up to six months old.
When will the RSV vaccinations for infants begin?
Vaccinations will begin next fall.
Where will the infant RSV vaccines be administered?
The vaccines will be administered in Madrid hospitals’ maternity wards and children’s university hospitals located in the capital.
What illnesses does the RSV vaccine protect against?
The vaccine aims to protect against illnesses such as bronchiolitis and pneumonia.
Has Madrid launched an infant immunization campaign previously?
Yes, Madrid launched its infant immunization campaign two years prior to the source material.
What were the vaccination rates for infants in the last campaign?
During the last campaign, which ran from Oct. 1, 2024, to March 31, 82% of children up to six months old were vaccinated. Vaccination coverage reached 96% among newborns.
How have RSV vaccinations impacted RSV cases in Madrid?
The General Directorate of Public Health reports that the infant immunization program has led to important decreases in RSV cases:
- A 17.6% decrease in RSV cases registered in primary care compared to the 2023/24 period.
- A 51.1% decrease compared to 2022, before the vaccine was administered.
Have RSV vaccinations reduced hospital admissions in Madrid?
Yes, the vaccination program has prevented 90% of hospital admissions for babies up to one year old.
Are RSV vaccines also available for adults in Madrid?
Yes, Madrid’s public health system will soon receive 100,000 doses of RSV vaccines for protection for elderly and vulnerable adults.
What illnesses in adults are they designed to prevent?
These vaccines are aimed to protect vulnerable adults from severe pneumonia, and complications such as heart failure.
What are the key takeaways from Madrid’s RSV vaccination program?
Here’s a summary of the key benefits:
- Reduced RSV Cases: Significant declines in RSV cases reported.
- Prevented Hospital Admissions: Prevention of 90% of hospital admissions for babies up to one year old.
- Wide coverage: High vaccination rates among infants.
- Expansion to Adults: inclusion of vulnerable adults in the vaccination program.